Biosynth, a supplier of critical raw materials to the life science industry, announced that it has acquired VIO Chemicals, a Zurich-based company with leading chemical R&D expertise and a glob .
Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the product life cycle from discovery to commercialisation.STAAD, Switzerland (BUSINESS WIRE) Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pe.
Critical raw materials supplier Biosynth (Staad, Switzerland) ) recently acquired German company celares, a leader in the development and manufacture of conjugate vaccines and bioconjugate drugs, activated PEGs and polymer-based drug delivery excipients, which will now be offered to the Swiss organisation’s existing pharma and diagnostics customer base, from GMP facilities located in Berlin, Germany. Click to read more.